Original Research

Published on 29 Jun 2023

Role of interleukin 1β and interleukin 10 variants on ocular toxoplasmosis in Brazilian individuals

in Inflammatory Eye Diseases

Warlen Miiller Rocha Araujo
Christiane Maria Ayo
Mariana Previato
Geraldo Magela de Faria
Fábio Batista Frederico
Rubens Camargo Siqueira
Gildásio Castello de Almeida
Vera Lúcia Pereira-Chioccola
Luiz Carlos de Mattos
Cinara Cássia Brandão

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1183167

1,225 views
2 citations

Case Report

Published on 09 Jun 2023

A rare case report of panuveitis with retinochoroidal involvement, retinitis, and retinal vasculitis due to extensive tinea corporis

in Inflammatory Eye Diseases

Vinaya Kumar Konana
Kalpana Babu

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1174414

978 views

Case Report

Published on 05 Jun 2023

Case Report: Scleral hyperpigmentation associated with oral hydroxychloroquine use

in Inflammatory Eye Diseases

Caroline Maretz
Felix Omoruyi
Rachel A. F. Wozniak

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1192019

1,786 views
1 citation

Original Research

Published on 02 Jun 2023

Risk factors for the development of macular edema in children with uveitis

in Inflammatory Eye Diseases

Ronit Friling
Ori Berliner
Maya Eiger-Moscovich
Yi-Hsing Chen
Oren Tomkins-Netzer
Michal Kramer

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1134077

719 views

Mini Review

Published on 18 Apr 2023

CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions

in Inflammatory Eye Diseases

Alan R. Abraham
Panayiotis Maghsoudlou
David A. Copland
Lindsay B. Nicholson
Andrew D. Dick

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1184937

4,140 views
6 citations

Original Research

Published on 23 Mar 2023

Aberration in myeloid-derived pro-angiogenic cells in type-2 diabetes mellitus; implication for diabetic retinopathy?

in Inflammatory Eye Diseases

Mahnaz Shariatzadeh
Trishika R.R. Binda
Conny van Holten-Neelen
Josianne C. ten Berge
Jose P. Martinez Ciriano
King T. Wong
Willem A. Dik
Pieter J.M. Leenen

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1119050

941 views
2 citations

Mini Review

Published on 21 Mar 2023

An update on immunological and molecular tests and their impact in infectious uveitis

in Inflammatory Eye Diseases

Joanne Thomas
Nam V. Nguyen
Tolulope Fashina
Ye Huang
Steven Yeh
Christopher D. Conrady

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1132131

1,026 views

Mini Review

Published on 01 Mar 2023

Molecular mechanisms of TGFβ-mediated EMT of retinal pigment epithelium in subretinal fibrosis of age-related macular degeneration

in Inflammatory Eye Diseases

Fumiaki Higashijima
Mina Hasegawa
Takuya Yoshimoto
Yuka Kobayashi
Makiko Wakuta
Kazuhiro Kimura

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.1060087

2,537 views
2 citations

Opinion

Published on 06 Feb 2023

Should we reconsider first-line treatments for glaucoma in the setting of meibomian gland dysfunction and ocular surface disease: Glaucoma treatments and its effects

in Inflammatory Eye Diseases

Annie Nguyen

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.958955

1,281 views

Original Research

Published on 31 Jan 2023

Scleritis in rheumatoid arthritis: Before and during biologic era

in Inflammatory Eye Diseases

Daphne P. C. Vergouwen
Pascal H. P. de Jong
Marco W. J. Schreurs
Josianne C. Ten Berge
Aniki Rothova

Frontiers in Ophthalmology

doi 10.3389/fopht.2023.1106419

2,162 views

Original Research

Published on 26 Jan 2023

The full range of ophthalmological clinical manifestations in systemic lupus erythematosus

in Inflammatory Eye Diseases

Nikita Kedia
Vincent Theillac
Manuel Paez-Escamilla
Chad Indermill
Denise S. Gallagher
Raphaël Adam
Anne Lise Qu-Knafo
Fatima Amari
Caroline Bottin
Géraldine Chotard

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.1055766

4,258 views
2 citations

Case Report

Published on 05 Jan 2023

Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab

in Inflammatory Eye Diseases

Wan-Hua Cho
Wei-Yu Chiang

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.1021574

1,232 views

Mini Review

Published on 13 Sep 2022

Advances in the microbiological diagnosis of herpetic retinitis

in Inflammatory Eye Diseases

Julie Gueudry
Bahram Bodaghi

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.990240

1,414 views

Mini Review

Published on 22 Aug 2022

Acute retinal necrosis: A mini review

in Inflammatory Eye Diseases

Florence Hoogewoud
Daniele C. Rossi
Theodor Stappler
Yan Guex-Crosier

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.916113

4,834 views
2 citations

Mini Review

Published on 15 Aug 2022

Biologic therapies for juvenile idiopathic arthritis-associated uveitis

in Inflammatory Eye Diseases

Gianluca Dini
Giovanni Battista Dell’Isola
Alfredo Beccasio
Giuseppe Di Cara
Alberto Verrotti
Carlo Cagini

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.954901

1,912 views

Editorial

Published on 05 Aug 2022

Editorial: Insights in inflammatory eye diseases: 2021

in Inflammatory Eye Diseases

Heping Xu
Narsing A. Rao

Frontiers in Ophthalmology

doi 10.3389/fopht.2022.962522

880 views

Navigation group

Articles

Role of interleukin 1β and interleukin 10 variants on ocular toxoplasmosis in Brazilian individuals

A rare case report of panuveitis with retinochoroidal involvement, retinitis, and retinal vasculitis due to extensive tinea corporis

Case Report: Scleral hyperpigmentation associated with oral hydroxychloroquine use

Risk factors for the development of macular edema in children with uveitis

CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions

Aberration in myeloid-derived pro-angiogenic cells in type-2 diabetes mellitus; implication for diabetic retinopathy?

An update on immunological and molecular tests and their impact in infectious uveitis

Molecular mechanisms of TGFβ-mediated EMT of retinal pigment epithelium in subretinal fibrosis of age-related macular degeneration

Should we reconsider first-line treatments for glaucoma in the setting of meibomian gland dysfunction and ocular surface disease: Glaucoma treatments and its effects

Scleritis in rheumatoid arthritis: Before and during biologic era

The full range of ophthalmological clinical manifestations in systemic lupus erythematosus

Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab

Advances in the microbiological diagnosis of herpetic retinitis

Acute retinal necrosis: A mini review

Biologic therapies for juvenile idiopathic arthritis-associated uveitis

Editorial: Insights in inflammatory eye diseases: 2021